IMUC (EOM Pharmaceutical Holdings) EBIT per Share: $-2.97 (TTM As of Jun. 2018)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

What is EOM Pharmaceutical Holdings EBIT per Share?

EOM Pharmaceutical Holdings IMUC EBIT per Share is $-2.97 as of Jun. 2018.

EOM Pharmaceutical Holdings's EBIT per Share for the three months ended in Jun. 2018 was $-0.07. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2018 was $-2.97.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for EOM Pharmaceutical Holdings's EBIT per Share or its related term are showing as below:

IMUC's 3-Year EBIT Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 15.5
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

EOM Pharmaceutical Holdings's EBIT for the three months ended in Jun. 2018 was $-0.31 Mil.

EOM Pharmaceutical Holdings (OTCPK:IMUC) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

EOM Pharmaceutical Holdings EBIT per Share Related Terms

EOM Pharmaceutical Holdings EBIT per Share Historical Data

* Premium members only.

The historical data trend for EOM Pharmaceutical Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EOM Pharmaceutical Holdings EBIT per Share Chart

EOM Pharmaceutical Holdings Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

EBIT per Share

Get a 7-Day Free Trial

-69.56

-62.52

-58.06

-74.19

-9.33

EOM Pharmaceutical Holdings Quarterly Data
	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18
EBIT per Share	Get a 7-Day Free Trial															-10.20	-2.55	-0.10	-0.25	-0.07

EOM Pharmaceutical Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

EOM Pharmaceutical Holdings's EBIT per Share for the fiscal year that ended in Dec. 2017 is calculated as

	EBIT per Share		(A: Dec. 2017 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-13.429	/	1.440
=	-9.33

EOM Pharmaceutical Holdings's EBIT per Share for the quarter that ended in Jun. 2018 is calculated as

	EBIT per Share		(Q: Jun. 2018 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.307	/	4.191
=	-0.07

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.97

Frequently Asked Questions Learn more about EBIT per Share →

What does a EBIT per Share of $-2.97 mean?

EOM Pharmaceutical Holdings (IMUC) has a EBIT per Share of $-2.97 as of Jun. 2018. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on EOM Pharmaceutical Holdings and its competitors.

Is EOM Pharmaceutical Holdings' EBIT per Share too high?

EOM Pharmaceutical Holdings' current EBIT per Share is $-2.97.

How does EOM Pharmaceutical Holdings' EBIT per Share compare to MNTMD and RTTR?

EOM Pharmaceutical Holdings' EBIT per Share of $-2.97 can be compared against companies in the Biotechnology industry. The industry median EBIT per Share is 15.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT per Share for a Biotechnology company?

The median EBIT per Share among Biotechnology companies is 15.50, based on 1,171 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT per Share mean?

A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on EOM Pharmaceutical Holdings and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EOM Pharmaceutical Holdings's current EBIT per Share is $-2.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is EOM Pharmaceutical Holdings stock overvalued right now?

EOM Pharmaceutical Holdings (IMUC) has a current EBIT per Share of $-2.97. The current EBIT per Share is $-2.97. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT per Share calculated?

EBIT per Share is calculated from a company's financial statements. For EOM Pharmaceutical Holdings (IMUC), the current EBIT per Share is $-2.97 as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EOM Pharmaceutical Holdings Business Description

Industry Healthcare Biotechnology

Comparable Companies XCNQ:AGN MNTMD RTTR OSL:ABT BZYR TSXV:COT TSXV:IBT USRM NVIV TSXV:NLTA WAR:RDG TIKRF TAUG ASX:ATX PTEO AURX GLPH XSAT:CLINE B BTHE IMUN

Address 136 Summit Avenue, Suite 100, Montvale, NJ, USA, 07645

Website https://www.eompharma.com

EOM Pharmaceutical Holdings Inc is a clinical-stage biotechnology company that is focused on developing drugs with the potential to transform therapeutic paradigms and improve quality of life in patients suffering from debilitating and sometimes deadly diseases. Its products have been approved in the U.S., rheumatoid arthritis, and inflammatory conditions of the gastrointestinal tract such as Crohn's Disease and Ulcerative Colitis as well as various retina disorders characterized by a breakdown of the blood-retinal barrier such as diabetic retinopathy, Aged related macular degeneration and retinal vein occlusion among others. Its pipeline includes its compound EOM613, an investigational novel dynamically dual-acting immunomodulator.